What Does Teva’s Exit From PhRMA Suggest About Its Priorities?

Teva Insists Its Memberships And Investments Must Be ‘Properly Seated’

07 Feb 2023

Seemingly in one of the first decisions overseen by the company’s new CEO Richard Francis, Teva will not sit at the table of the US brand industry trade association, the Pharmaceutical Research and Manufacturers of America, better known as PhRMA.

Exit — How will Teva approach its novel pipeline under Francis? • Source: Shutterstock

With an entrenched hybrid business model and novel assets in its pipeline, Teva has called time on its membership with the powerful US brand industry trade association, the Pharmaceutical Research and Manufacturers of America, or PhRMA, after six-and-a-half years.

Teva’s decision comes weeks after the company’s new CEO, Richard Francis, suggested the potential for clarity on the firm’s long-term...